Kibo Ventures was born in 2012 in Madrid (Spain) with the mission of empowering diverse European tech entrepreneurs to solve big problems and helping them scale.

Our team is a combination of operational and investment experts with deep international networks in Europe and US including some of the best founders, investors and corporates. Since 2012, we have built one of the largest tech investment teams in Southern Europe.

Our team and investors are committed to impact, diversity and believe in driving global positive impact while achieving top returns. We include social and environmental criteria in our investments.

Recently Kibo Ventures launched Nzyme, a private equity fund that supports exceptional teams to innovate and grow their entrepreneurial ventures. Just as enzymes do in living organisms, our goal is to accelerate transformation and to facilitate the integration of companies to create market-leading businesses.

Our numbers

5 funds

€300M AUM Assets Under Management

70+ companies invested

1 IPO and 4 Unicorns

14+ relevant exits to companies like Paypal, AirBnB, Groupon and others

3 offices in Madrid, Barcelona and Lisbon

25+ entrepreneurs as LPs in our funds

20%+ female founders

Investment thesis

We invest in early-stage companies that are ready to scale globally

We lead and co-lead pre-Series A or Series A rounds

We are sector agnostic: both consumer and enterprise software

Our initial investment range is €2m - €6m, targeting 10-20% ownership

We look for teams building global companies that leverage local development and operations, while scaling in bigger markets

We favor proven product-market fit and readiness to scale massively

We are always open to co-invest with the right partners

How we help

We listen, respect, hope for the best and are willing to help

Recruiting

We have helped our portfolio companies hire 100+ key employees. Several portfolio companies over 200 employees.

Building & growing

We supported our portfolio companies via strategy, network and sales actions, resulting in over $4B of total portfolio value.

Fundraising

64% of Fund II companies have exited or raised Series B+

Exiting

We have sold 14+ companies to relevant global companies.